Publicacións en colaboración con investigadores/as de University of Nottingham (18)

2024

  1. Inflammatory bowel disease induces pathological α-synuclein aggregation in the human gut and brain

    Neuropathology and Applied Neurobiology, Vol. 50, Núm. 1

2023

  1. Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417))

    Nature communications

  2. European Physician Survey Characterizing the Clinical Pathway and Treatment Patterns of Patients Post-Myocardial Infarction

    Advances in Therapy, Vol. 40, Núm. 1, pp. 233-251

2022

  1. Development of a nanocapsule-loaded hydrogel for drug delivery for intraperitoneal administration

    International Journal of Pharmaceutics, Vol. 622

  2. New insights into the genetic etiology of Alzheimer's disease and related dementias

    Nature genetics, Vol. 54, Núm. 4, pp. 412-436

2021

  1. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

    Nature communications, Vol. 12, Núm. 1, pp. 3417

  2. Overcoming challenges in developing small molecule inhibitors for GPVI and CLEC-2

    Platelets, Vol. 32, Núm. 6, pp. 744-752

2020

  1. Mechanistic investigations into the encapsulation and release of small molecules and proteins from a supramolecular nucleoside gel in vitro and in vivo

    Journal of Controlled Release, Vol. 317, pp. 118-129

  2. Polyphosphazenes for the delivery of biopharmaceuticals

    Journal of Applied Polymer Science, Vol. 137, Núm. 25

2019

  1. A novel low molecular weight nanocomposite hydrogel formulation for intra-tumoural delivery of anti-cancer drugs

    International Journal of Pharmaceutics, Vol. 565, pp. 151-161

  2. Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (Nature Genetics, (2019), 51, 3, (414-430), 10.1038/s41588-019-0358-2)

    Nature Genetics

  3. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

    Nature Genetics, Vol. 51, Núm. 3, pp. 414-430

  4. Structure-Optimized Interpolymer Polyphosphazene Complexes for Effective Gene Delivery against Glioblastoma

    Advanced Therapeutics, Vol. 2, Núm. 3

2016

  1. Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond

    PLoS Pathogens, Vol. 12, Núm. 7

2015

  1. Ligand residence time at G-protein-coupled receptors - Why we should take our time to study it

    Molecular Pharmacology, Vol. 88, Núm. 3, pp. 552-560

2014

  1. Processed pseudogenes acquired somatically during cancer development

    Nature Communications, Vol. 5

2013

  1. Striking structural dynamism and nucleotide sequence variation of the transposon Galileo in the genome of Drosophila mojavensis

    Mobile DNA, Vol. 4, Núm. 1

1996

  1. Over the counter drugs: Both doctors and pharmacists should prescribe better [13]

    British Medical Journal